ATE314864T1 - Verfahren zur schützung gegen ionisierende strahlung oder chemotherapeutisches-arzneimittel- schaden durch in vivo gentherapie - Google Patents

Verfahren zur schützung gegen ionisierende strahlung oder chemotherapeutisches-arzneimittel- schaden durch in vivo gentherapie

Info

Publication number
ATE314864T1
ATE314864T1 AT99921357T AT99921357T ATE314864T1 AT E314864 T1 ATE314864 T1 AT E314864T1 AT 99921357 T AT99921357 T AT 99921357T AT 99921357 T AT99921357 T AT 99921357T AT E314864 T1 ATE314864 T1 AT E314864T1
Authority
AT
Austria
Prior art keywords
subject
ionizing radiation
gene therapy
protection against
vivo gene
Prior art date
Application number
AT99921357T
Other languages
English (en)
Inventor
Joel S Greenberger
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of ATE314864T1 publication Critical patent/ATE314864T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99921357T 1998-05-11 1999-05-07 Verfahren zur schützung gegen ionisierende strahlung oder chemotherapeutisches-arzneimittel- schaden durch in vivo gentherapie ATE314864T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/075,532 US6221848B1 (en) 1998-05-11 1998-05-11 Protection of the esophagus from chemotherapeutic or irradiation damage by gene therapy

Publications (1)

Publication Number Publication Date
ATE314864T1 true ATE314864T1 (de) 2006-02-15

Family

ID=22126381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921357T ATE314864T1 (de) 1998-05-11 1999-05-07 Verfahren zur schützung gegen ionisierende strahlung oder chemotherapeutisches-arzneimittel- schaden durch in vivo gentherapie

Country Status (10)

Country Link
US (1) US6221848B1 (de)
EP (1) EP1077728B1 (de)
JP (1) JP2002514608A (de)
AT (1) ATE314864T1 (de)
AU (1) AU769805B2 (de)
CA (1) CA2331569A1 (de)
DE (1) DE69929327T2 (de)
ES (1) ES2257049T3 (de)
PT (1) PT1077728E (de)
WO (1) WO1999058154A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887856B1 (en) * 1993-10-15 2005-05-03 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
EP2307542A1 (de) * 2008-06-26 2011-04-13 Spectrum Health Verfahren zur behandlung oder vorbeugung von strahlungsschäden mittels in-vivo-gentherapie
EP2300607A2 (de) * 2008-06-26 2011-03-30 Spectrum Health Innovations, LLC Verfahren zur behandlung und verhinderung von strahlungsschäden mithilfe genetisch modifizierter mesenchymaler stammzellen
WO2012068081A1 (en) * 2010-11-15 2012-05-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagatis
BR112023024140A2 (pt) * 2021-05-18 2024-02-06 Ltt Bio Pharma Co Ltd Composição farmacêutica que compreende uma superóxido dismutase lecitinizada e uso de uma superóxido dismutase lecitinizada para tratar ou prevenir um distúrbio associado com a administração de um agente anticâncer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
ES2083357T3 (es) 1987-03-14 1996-04-16 Boehringer Ingelheim Int Manganeso-superoxido-dismutasa humana (hmn-sod).
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
IL109112A0 (en) 1993-03-24 1994-06-24 Boehringer Ingelheim Pharma Pharmaceutical compositions containing human manganese superoxide dismutase
US5599712A (en) * 1993-10-15 1997-02-04 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
WO1998000160A1 (en) * 1996-06-28 1998-01-08 Nat Jewish Ct Immun & Respirat USE OF THIOREDOXIN-LIKE MOLECULES FOR INDUCTION OF MnSOD TO TREAT OXIDATIVE DAMAGE

Also Published As

Publication number Publication date
DE69929327D1 (de) 2006-03-30
EP1077728A1 (de) 2001-02-28
CA2331569A1 (en) 1999-11-18
JP2002514608A (ja) 2002-05-21
DE69929327T2 (de) 2006-09-07
AU3859399A (en) 1999-11-29
ES2257049T3 (es) 2006-07-16
US6221848B1 (en) 2001-04-24
PT1077728E (pt) 2006-05-31
AU769805B2 (en) 2004-02-05
EP1077728B1 (de) 2006-01-04
WO1999058154A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
GB0223380D0 (en) Combination therapy
WO2006035204A3 (en) Combination comprising zd6474 and an imatinib
HK1071310A1 (en) Combination therapy for the treatment of cancer
IL169702A0 (en) Combination therapy of zd6474 with 5-fu or/and cpt-11
MXPA04004355A (es) Tratamiento de combinacion que comprende zd6474 y un taxano.
CY1111547T1 (el) Συνδυασμος zd6474 και πεμετρεξεδης
MX2007005356A (es) Terapia de combinacion que comprende zd6474 y un antiadrogenico.
HK1089667A1 (en) Cancer combination therapy comprising azd2171 and zd1839
WO2007071970A3 (en) Combination of azd2171 and pemetrexed
IL177952A0 (en) Combination therapy including azd2171 plus cpt-11 and 5-fu
WO2005011572A3 (en) Combination of drugs for the treatment of neoplasms
ZA200600188B (en) Combination therapy
NO20064753L (no) Kombinasjonsterapi
ATE314864T1 (de) Verfahren zur schützung gegen ionisierende strahlung oder chemotherapeutisches-arzneimittel- schaden durch in vivo gentherapie
WO2007003933A3 (en) Combination therapy of cancer with azd2171 and gemcitabine
WO2005092385A3 (en) Combination therapy of azd2171 and a taxane
WO2004112801A3 (en) Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
GB0223379D0 (en) Combination therapy
MXPA05008879A (es) Una terapia combinada que comprende un derivado de indolopirrolocarbazol y otro agente antitumoral.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties